The relationship between body weight and cardiometabolic disease may vary substantially by race/ethnicity.
O
verweight and obesity are well-known cardiometabolic risk factors (1) (2) (3) . However, some persons with normal weight have elevated cardiometabolic risk (4 -7) , and the relationship between excess adiposity and cardiometabolic abnormality may vary by race/ethnicity (4 -7) . Although some information is available regarding the prevalence and correlates of metabolic abnormality but normal weight (MAN) in non-Hispanic whites, non-Hispanic African Americans, and Mexican Americans (4, 5) , no direct comparisons have been made among East or South Asians who are at high risk for cardiometabolic abnormalities, even at relatively low levels of body mass index (BMI) (8 -13) .
We therefore compared the prevalence of MAN among members of 5 racial/ethnic groups, including 2 Asian subgroups, by using data from 2 large, wellcharacterized community-based U.S. cohorts. We also examined the correlates associated with MAN in the 4 racial/ethnic minority groups compared with whites. Lastly, we determined the BMI values in the racial/ethnic minority participants that would yield a MAN prevalence equal to that in whites with a BMI of 25 kg/m 2 .
(white, Chinese American, African American, and Hispanic) aged 45 to 84 years recruited from the greater New York, New York; Baltimore, Maryland; Chicago, Illinois; Los Angeles, California; Minneapolis-Saint Paul, Minnesota; and Winston-Salem, North Carolina, areas. Baseline data collection and examinations were conducted between July 2000 and July 2002. Questionnaires were used to assess demographic and behavioral characteristics, and seated blood pressure readings, anthropometric measurements, and abdominal and cardiac computed tomography (CT) scans were obtained. Physical activity was assessed by using the Typical Week Physical Activity Questionnaire (15) . Fasting serum glucose levels were evaluated by using the glucose oxidase method (Ortho Clinical Diagnostics). Insulin levels were determined by the Access system (Beckman Coulter) and harmonized with an Elecsys assay (Roche Diagnostics). C-reactive protein values were assessed by using a BN II nephelometer (N HighSensitivity C-reactive protein test, Dade Behring). Total cholesterol and high-density lipoprotein cholesterol (HDL-C) levels were determined by using the cholesterol oxidase method (Roche Diagnostics), and lowdensity lipoprotein cholesterol concentrations were calculated. Triglyceride levels were measured by using Triglyceride GB reagent (Roche Diagnostics). Usual dietary intake over the past year was assessed by using a 120-item food-frequency questionnaire that was validated in white, African American, and Hispanic populations and modified to include Chinese foods (16) .
MASALA Study
The MASALA study involved measures and methods similar to those of MESA to allow for specific crossracial/ethnic comparisons (17) . Its design and objectives also have been described (17) . In brief, MASALA studied a community-based sample of South Asian Americans who were aged 40 to 84 years, had no previously known cardiovascular disease, and were living in the greater San Francisco Bay and Chicago areas. To be eligible for the study, participants had to report South Asian ethnicity (defined as having 3 or more grandparents born in India, Pakistan, Nepal, Bangladesh, or Sri Lanka) and be able to speak and read English, Hindi, or Urdu. All other eligibility criteria were identical to those of MESA (17) . Recruitment occurred between October 2010 and March 2013. All participants were screened by telephone and invited to either the University of California, San Francisco, or the Northwestern University field center for a baseline clinical examination (17) . Bilingual study staff assisted participants in completing the questionnaires, which were the same as those used in MESA. Because dietary intake is distinct in South Asians, the MASALA investigators used the SHARE (Study of Health Assessment and Risk in Ethnic groups) food-frequency questionnaire, which was developed for and validated in South Asians (17) . Mean caloric intake was calculated by summing the product of the frequency of consumption, nutrient composition, and portion size of each item across all food items (18) .
The protocols used in the MASALA study for seated blood pressure and anthropometry were the same as those used in MESA. After resting in a seated position for 5 minutes, each participant had his or her blood pressure assessed with an automated blood pressure machine (V100 Vital Signs Monitor, GE Healthcare). Seated blood pressure was measured 3 times, and the last 2 readings were averaged to determine systolic and diastolic blood pressure. Participant weight was measured with a standing balance beam or digital scale, height with a stadiometer. Body mass index was calculated as weight in kilograms divided by height in square meters. Waist circumference was determined by using a flexible tape measure at the site of maximum circumference, halfway between the lower ribs and the anterior superior iliac spine. The circumference was measured twice, and the average was used for analysis. Blood samples were collected after a 12-hour overnight fast. Total cholesterol, triglyceride, and HDL-C levels were analyzed by enzymatic methods, and lowdensity lipoprotein cholesterol concentrations were calculated. Fasting plasma glucose levels were analyzed by using the hexokinase method. Serum insulin was measured by the sandwich immunoassay method (Elecsys 2010, Roche Diagnostics) (19). As in MESA, Luminex adipokine panel A (EMD Millipore) was used to measure adiponectin and resistin levels. The interassay coefficient of variations was 2.34% to 4.12% for adiponectin and 3.25% to 5.03% for resistin (19). Computed tomography scans of the abdomen (Philips Medical Systems, Toshiba Medical Systems, and Siemens Medical Solutions) were used to assess visceral, subcutaneous, and intermuscular fat mass. Noncontrast cardiac CT images were obtained with a cardiac-gated CT scanner (Phillips 16D or Toshiba MSD Aquillion 64 at the University of California, San Francisco, and Siemens Sensation Cardiac 64 at Northwestern University) to assess pericardial fat volume and hepatic fat attenuation. Measurement methods and reading centers were similar to those used in MESA (20) .
Classification of Cardiometabolic Abnormalities
We used National Cholesterol Education ProgramAdult Treatment Panel III criteria to consider 4 cardiometabolic abnormalities (21) . Decreased HDL-C was defined as a level lower than 1.03 mmol/L (<40 mg/dL) in men or 1.29 mmol/L (<50 mg/dL) in women, or any use of lipid-lowering medication (22) . Elevated triglyceride was classified as a fasting triglyceride level of 1.7 mmol/L (150 mg/dL) or greater (22) . Elevated glucose was classified as a fasting plasma glucose level of 5.6 mmol/L (100 mg/dL) or greater (23) or any use of glucose-lowering medication. High blood pressure was defined as 130/85 mm Hg or greater or any use of antihypertensive medication. The waist circumference criterion was not used because of collinearity with BMI (correlation coefficient, 0.85; P < 0.0001). On the basis of previous literature, cardiometabolic abnormality was defined as the presence of 2 or more of the aforementioned components (4, 24 -28). 
Statistical Analysis
Analyses were conducted by using pooled data from the 2 cohorts. Participant characteristics were described as means, geometric means, and percentages by race/ethnicity. Differences in these characteristics across race/ethnicity were assessed by using chi-square tests or analysis of variance as appropriate. The prevalence of metabolic abnormality was calculated by BMI strata. Prevalence ratios of MAN in Chinese, African American, Hispanic, and South Asian participants compared with whites were estimated by using Poisson models with robust SEs (29). Multivariate models were adjusted for age, sex, education, physical activity, daily caloric intake, alcohol use, smoking status, hepatic fat 
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Normal Weight Overweight Obese W h i t e S o u t h A s i a n H i s p a n i c C h i n e s e A m e r i c a n A f r i c a n A m e r i c a n W h i t e S o u t h A s i a n H i s p a n i c C h i n e s e A m e r i c a n A f r i c a n A m e r i c a n W h i t e S o u t h A s i a n H i s p a n i c C h i n e s e A m e r i c a n A f r i c a n A m e r i c a n We then used a search algorithm to find the BMI values for each of the other 4 groups that resulted in approximately the same marginal expected number of abnormalities. We also used this procedure to obtain BMI values for South Asian, African American, Hispanic, and Chinese American participants, resulting in an expected MAN prevalence approximately equal to that among whites with a BMI of 25 kg/m 2 , based on a Poisson model for MAN, also adjusting for sex and a 4-knot spline in age. Confidence intervals for the BMI estimates were obtained by using bootstrap resampling. All analyses were performed with SAS, version 9.3 (SAS Institute).
The MESA study protocol was approved by the institutional review boards (IRBs) of the 6 field centers and the National Heart, Lung, and Blood Institute (NHLBI). The IRBs of Northwestern University and the University of California, San Francisco, approved the MASALA study protocol. The analysis was approved by the IRB at Emory University.
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RESULTS
The total sample of 7617 participants comprised 2622 whites, 803 Chinese Americans, 1893 African Americans, and 1496 Hispanic Americans from MESA and 803 South Asians from MASALA. The sample also was made up of 1950 (25.6%) normal-weight, 3163 (41.5%) overweight, and 2504 (32.9%) obese participants. Overall, the South Asian participants were significantly younger than members of all other racial/ethnic groups, and this group had a significantly higher proportion of men compared with all other racial/ethnic groups except for Chinese Americans (Appendix Table 1 , available at Annals.org).
Prevalence of MAN
The overall prevalence of normal weight and obesity varied by race/ethnicity, with white and Chinese American participants having the highest prevalence of normal weight (32.3% and 40.2%, respectively) and African American and Hispanic participants having the highest prevalence of obesity (45.4% and 38.6%, respectively) (Figure 1, top) . Overall, 29.1% of the participants with normal weight had the MAN phenotype, whereas 35.8% of those with obesity were metabolically normal. The prevalence of MAN varied significantly by race/ethnicity: 21.0% (95% CI, 18.4% to (Figure 1,  bottom) . These patterns were consistent by sex in all racial/ethnic groups except for South Asians, in whom the prevalence of MAN was greater in men (57.4%) than women (26.4%). In sensitivity analyses using the standard BMI criterion for the 2 Asian American subgroups, the prevalence of MAN was 40.4% in Chinese American and 47.9% in South Asian participants. Among participants with 2 or more cardiometabolic abnormalities, the most common risk factor combination in whites was hypertension and a low HDL-C level (40.0%). In all other racial/ethnic groups, the risk factor combination of high glucose and low HDL-C levels was most common (48.7% in South Asians, 37.3% in Chinese Americans, 36.4% in African Americans, and 37.9% in Hispanics). Appendix Table 2 (available at Annals.org) details the prevalence of risk factor combinations among all racial/ethnic groups.
Among participants with MAN, South Asians were significantly younger than members of all other racial/ ethnic groups ( Table 1) . A significantly greater proportion of South Asians than whites or Hispanics had diabetes. Mean daily caloric intake was significantly higher in South Asians than members of any other racial/ethnic group except Hispanics. Levels of circulating adiponectin were significantly lower in South Asians than members of all other racial/ethnic groups. South Asians also had less hepatic fat attenuation (more fat in the liver) than all other racial/ethnic groups and less pericardial fat volume than all other groups except African Americans. Appendix Table 3 (available at Annals.org) details the characteristics of participants who were normal weight regardless of metabolic phenotype.
Correlates of the MAN Phenotype
Compared with whites, the prevalence of MAN was approximately 100% greater in South Asians, 50% in Chinese and African Americans, and 80% in Hispanics ( Table 2) . It was also higher in older participants and those with greater pericardial fat volume and lower in those with higher educational status and greater hepatic fat attenuation (less fat in the liver). In a multivariable-adjusted model, South Asian, Chinese, African American, and Hispanic race/ethnicity remained independently associated with MAN, as did older age, pericardial fat volume, educational status, and hepatic fat attenuation. Adjustment for age, sex, education, smoking status, alcohol use, physical activity, daily caloric intake, hepatic fat attenuation, and pericardial fat volume did not explain the differences in MAN among the study groups.
In restricted models including only normal-weight persons with measured visceral fat mass, adiponectin, and resistin (Appendix Table 4 , available at Annals .org), MAN was more prevalent in South Asians, Chinese Americans, African Americans, and Hispanics than whites. In multivariable-adjusted models, the prevalence of MAN remained greater in South Asians and Hispanics, but not in Chinese and African American participants, compared with whites.
Ethnic-Specific BMI Values
We estimated the BMI values at which the expected numbers of metabolic abnormalities among South Asians, Chinese Americans, African Americans, and Hispanics would equal those among whites with a BMI of 25.0 kg/m 2 
DISCUSSION
In this cross-sectional study of 2 large communitybased cohorts including participants from several racial/ethnic groups in the United States, we found that nearly a third of those who were normal weight had cardiometabolic abnormalities. Furthermore, MAN prevalence varied by race/ethnicity, with a significantly higher proportion of South Asians and Hispanics, followed by Chinese and African Americans, having this phenotype compared with whites. Adjustment for demographic, behavioral, and ectopic fat variables did not explain these differences. For a MAN prevalence equivalent to that in whites with a BMI of 25 kg/m 2 , the corresponding BMI values were lower in all racial/ethnic minority groups, suggesting that BMI alone is a poor indicator of cardiometabolic risk in most of these populations. A recent, nationally representative study assessing the prevalence and correlates of MAN in whites, African Americans, and Mexican Americans reported that 23.5% of all normal-weight adults had metabolic abnormalities (4). This percentage is lower than our finding of 29%, which partly may be a result of the younger mean age of the prior study's participants. Another difference is that our study included South Asian and Chinese American participants as well as measures of ectopic fat and adipokine levels; a previous study comparing the MESA and MASALA populations found significant differences in ectopic fat distribution and adipokine levels between South Asians and the 4 MESA racial/ethnic groups (30). Although these differences may partially account for the increased predisposition to insulin resistance and type 2 diabetes among South Asians, adjustment for ectopic fat measures and adipokine levels did not explain the difference in MAN among racial/ethnic groups in our study. Our findings also are consistent with those of a larger, longitudinal study, which found that a BMI cut point of 30 kg/m 2 in whites was equivalent to lower BMI cut points for South Asians, Chinese Americans, and African Americans in terms of diabetes incidence (13) . Finally, our results build on those of a study that found elevated glucose and lipid levels at lower BMI values in non-European (South Asian, Chinese, and Aboriginal Canadian) versus European populations (12) . Taken together, these findings suggest that established BMI cut points may be practical markers for detecting overweight but may not necessarily correlate with overall cardiometabolic health and that race/ethnicity alone may be a better predictor of cardiometabolic risk in racial/ethnic minority populations.
Our study has several strengths. We investigated cardiometabolic abnormalities in normal-weight persons from 5 U.S. racial/ethnic groups, including the relatively understudied South Asian and Chinese American populations, in whom previous studies showed cardiometabolic abnormalities developing at lower BMI levels than in other racial/ethnic groups (11-13). Furthermore, our study used harmonized data from 2 large cohorts that included several radiographic measures of body composition to assess ectopic fat and adipokine levels.
However, our results also should be interpreted within the context of several limitations. The difference in timing of data collection between studies (2000 to 2002 for MESA and 2010 to 2013 for MASALA) may have resulted in some differences in the prevalence of overweight and obesity between the 2 cohorts. Because the initial enrollment of the MESA cohort began a decade and a half ago, secular changes may have occurred in the adoption of healthier behaviors, such as a decreased prevalence of smoking (31). However, the prevalence of obesity and diabetes has not decreased substantially during the past 2 decades (32-34). Thus, we do not believe that the prevalence of metabolic abnormalities observed in the MESA participants would be much different from that observed in a current sample of middle-to older-aged adults. Furthermore, MESA and MASALA used different food-frequency questionnaires, limiting our ability to assess whether dietary patterns contribute to MAN prevalence. Of note, adjustment for daily caloric intake did not explain differences in MAN prevalence among racial/ethnic groups. Although the MASALA and MESA cohorts are community-based samples, neither is nationally representative; therefore, the results may not be generalizable to younger persons or South Asians and Chinese Americans born in the United States.
In conclusion, our findings suggest a high prevalence of cardiometabolic abnormality among normalweight persons, particularly those in racial/ethnic minority populations. This disparity cannot be explained by differences in demographic, behavioral, or ectopic fat measures. Therefore, clinicians using overweight and obesity as the main criteria for cardiometabolic screening, as currently recommended by the U.S. Preventive Services Task Force for diabetes testing (35), may fail to identify cardiometabolic abnormalities in many patients from racial/ethnic minority groups. Although the Task Force recommends earlier screening in racial/ethnic minority populations, testing for cardiometabolic abnormalities in normal-weight and underweight members of these groups also may be an important consideration. Future research is needed to identify the prospective associations between MAN and incident diabetes and cardiovascular disease in various racial/ethnic groups. 
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